Select Page
A jury on Tuesday said drugmaker Johnson & Johnson must pay $8 billion to a man who accused the company of failing to properly warn that its antipsychotic Risperdal could cause breast growth in men, according to Reuters. Nicholas Murray had previously been awarded $1.75 million in the case in 2015 after a jury found the company failed to warn of the risk of the condition, gynecomastia. While a Pennsylvania appeals court upheld the verdict last February, it reduced it to $680,000. Plaintiffs in the mass tort case were previously prohibited under a 2014 ruling that found a New Jersey law prohibiting punitive damages should apply to all cases, as J&J is headquartered in New Jersey.